JPH107552A5 - - Google Patents
Info
- Publication number
- JPH107552A5 JPH107552A5 JP1997060781A JP6078197A JPH107552A5 JP H107552 A5 JPH107552 A5 JP H107552A5 JP 1997060781 A JP1997060781 A JP 1997060781A JP 6078197 A JP6078197 A JP 6078197A JP H107552 A5 JPH107552 A5 JP H107552A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- sustained
- release formulation
- venlafaxine hydrochloride
- cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1400696P | 1996-03-25 | 1996-03-25 | |
| US60/014006 | 1996-03-25 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008064149A Division JP2008156374A (ja) | 1996-03-25 | 2008-03-13 | 持続放出性製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH107552A JPH107552A (ja) | 1998-01-13 |
| JPH107552A5 true JPH107552A5 (2) | 2004-12-24 |
| JP4771565B2 JP4771565B2 (ja) | 2011-09-14 |
Family
ID=21762972
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP06078197A Expired - Fee Related JP4771565B2 (ja) | 1996-03-25 | 1997-03-14 | 持続放出性製剤 |
| JP2008064149A Pending JP2008156374A (ja) | 1996-03-25 | 2008-03-13 | 持続放出性製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008064149A Pending JP2008156374A (ja) | 1996-03-25 | 2008-03-13 | 持続放出性製剤 |
Country Status (34)
| Country | Link |
|---|---|
| EP (2) | EP2881110A1 (2) |
| JP (2) | JP4771565B2 (2) |
| KR (1) | KR101096512B1 (2) |
| CN (2) | CN1090018C (2) |
| AR (1) | AR006519A1 (2) |
| AT (1) | ATE257011T1 (2) |
| AU (1) | AU727653B2 (2) |
| BR (1) | BR9701304A (2) |
| CA (1) | CA2199778C (2) |
| CO (1) | CO4761054A1 (2) |
| CY (1) | CY2442B1 (2) |
| CZ (1) | CZ291637B6 (2) |
| DE (1) | DE69727000T2 (2) |
| DK (1) | DK0797991T3 (2) |
| EG (1) | EG24198A (2) |
| ES (1) | ES2210454T3 (2) |
| HU (1) | HU224617B1 (2) |
| IL (1) | IL120382A (2) |
| IN (1) | IN187337B (2) |
| NO (2) | NO320355B1 (2) |
| NZ (1) | NZ314442A (2) |
| PA (1) | PA8426401A1 (2) |
| PE (1) | PE57198A1 (2) |
| PL (2) | PL195564B1 (2) |
| PT (1) | PT797991E (2) |
| PY (1) | PY970019A (2) |
| RU (1) | RU2176912C2 (2) |
| SK (1) | SK281530B6 (2) |
| SV (1) | SV1997000015A (2) |
| TR (1) | TR199700190A2 (2) |
| TW (1) | TW493993B (2) |
| UA (1) | UA44904C2 (2) |
| UY (1) | UY24613A1 (2) |
| ZA (1) | ZA972403B (2) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274171B1 (en) | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
| PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
| UA77145C2 (en) * | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
| JP3379461B2 (ja) * | 1998-08-06 | 2003-02-24 | 三菱電機株式会社 | コア部材の積層金型装置、コア部材の積層方法および電動機 |
| IE990406A1 (en) | 1999-05-20 | 2000-12-27 | Elan Corp Plc | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations. |
| EP1178780B1 (en) * | 1999-05-20 | 2007-07-18 | ELAN CORPORATION, Plc | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| ES2162746B1 (es) * | 1999-10-21 | 2003-02-16 | Lipotec Sa | Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion. |
| FR2805462B1 (fr) * | 2000-02-24 | 2003-08-15 | Therabel Res | Nouvelle forme galenique orale a liberation prolongee de la molsidomine |
| US6482440B2 (en) * | 2000-09-21 | 2002-11-19 | Phase 2 Discovery, Inc. | Long acting antidepressant microparticles |
| GB0025208D0 (en) * | 2000-10-13 | 2000-11-29 | Euro Celtique Sa | Delayed release pharmaceutical formulations |
| DE01988460T1 (de) * | 2000-10-19 | 2004-04-22 | Teva Pharmaceutical Industries Ltd. | Kristalline venlafaxinbase und neue venlafaxin-hydrochlorid-modifikationen sowie verfahren zu deren herstellung |
| SE0102887D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102886D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102888D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| IL146462A (en) | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
| HUP0104872A3 (en) * | 2001-11-13 | 2004-04-28 | Egis Gyogyszergyar Nyilvanosan | New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use |
| WO2003082805A1 (en) * | 2002-03-28 | 2003-10-09 | Synthon B.V. | Low water-soluble venlafaxine salts |
| AU2003219117A1 (en) * | 2002-03-28 | 2003-10-13 | Synthon B.V. | Extended release venlafaxine formulations |
| US6717015B2 (en) | 2002-03-28 | 2004-04-06 | Synthon Bv | Venlafaxine besylate |
| EP1596837A2 (en) * | 2003-02-07 | 2005-11-23 | Omega Farma Ehf | Sustained release formulations of venlafaxine |
| TW200503670A (en) * | 2003-03-28 | 2005-02-01 | Sandoz Ag | Venlafaxine compositions |
| PT1473030E (pt) | 2003-05-02 | 2007-01-31 | Dexcel Ltd | Formulação para um comprimido de libertação prolongada de venlafaxina |
| IN2003MU00504A (2) * | 2003-06-05 | 2005-05-13 | Alembic Ltd | |
| EP2112920B1 (en) | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| ATE336988T1 (de) | 2003-07-30 | 2006-09-15 | Pharmathen Sa | Venlafaxine hydrochloridformulierungen mit verzögerter freisetzung |
| WO2005048979A2 (en) * | 2003-10-06 | 2005-06-02 | Torrent Pharmaceuticals Limited | Pharmaceutical composition having casing with multiple micro tablets |
| HUP0303382A2 (hu) * | 2003-10-10 | 2005-08-29 | EGIS Gyógyszergyár Rt. | Venlafaxin-hidroklorid-tartalmú pelletek |
| EP1523981A1 (en) * | 2003-10-13 | 2005-04-20 | Wyeth | Extended release formulations of venlafaxine |
| EP1523979A1 (en) * | 2003-10-13 | 2005-04-20 | Wyeth | Extended release pharmaceutical dosage form |
| DE10359154A1 (de) | 2003-12-16 | 2005-07-28 | Krka Tovarna Zdravil, D.D. | Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I |
| ATE361743T1 (de) | 2004-02-04 | 2007-06-15 | Alembic Ltd | Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung |
| US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
| US7776358B2 (en) | 2004-07-22 | 2010-08-17 | Synthon Ip Inc. | Extended release venlafaxine besylate tablets |
| US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
| CN100463676C (zh) * | 2004-11-11 | 2009-02-25 | 成都康弘药业集团股份有限公司 | 一种盐酸文拉法辛控释片制剂及其制备方法 |
| ITFI20050206A1 (it) * | 2005-09-30 | 2007-04-01 | Valpharma Sa | Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione |
| US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
| WO2007112581A1 (en) * | 2006-04-03 | 2007-10-11 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
| HUE029173T2 (hu) | 2006-04-26 | 2017-02-28 | Alphapharm Pty Ltd | Szabályozott hatóanyag-leadású készítmények, amelyek tartalmaznak nem bevont diszkrét egység(ek)et és egy késleltetett hatóanyag-leadású mátrixot |
| US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| KR100791194B1 (ko) * | 2006-06-12 | 2008-01-02 | 코오롱제약주식회사 | 염산 벤라팍신의 경구 투여용 서방성 펠렛 및 그 제조방법 |
| CN102791258B (zh) * | 2010-02-03 | 2018-05-08 | 图必制药公司 | 雷沙吉兰的延长释放制剂及其用途 |
| WO2011132008A2 (en) | 2010-04-22 | 2011-10-27 | EGIS Gyűgyszergyár Nyilvánosan Múködő Részvény társaság | Controlled release pharmaceutical composition |
| US9789093B2 (en) | 2011-01-31 | 2017-10-17 | Serotech, Llc | Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder |
| CN103893151B (zh) * | 2012-12-31 | 2018-04-27 | 石药集团中奇制药技术（石家庄）有限公司 | 一种盐酸文拉法辛缓释胶囊及其制备方法 |
| WO2018213589A1 (en) | 2017-05-17 | 2018-11-22 | Confluence Pharmaceuticals, Llc | Formulations of homotaurines and salts thereof |
| CN114288273B (zh) * | 2022-02-11 | 2022-10-18 | 桂林华信制药有限公司 | 一种盐酸文拉法辛缓释胶囊及其生产工艺 |
| JP2023127913A (ja) * | 2022-03-02 | 2023-09-14 | 共和薬品工業株式会社 | ベンラファキシン塩酸塩含有顆粒 |
| JP2025120141A (ja) | 2024-02-03 | 2025-08-15 | 共和薬品工業株式会社 | ベンラファキシン塩酸塩含有徐放性顆粒の製造方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1561204A (en) * | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
| US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| IE56324B1 (en) * | 1982-12-13 | 1991-06-19 | American Home Prod | Phenethylamine derivatives and intermediates therefor |
| US4535186A (en) | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
| US4761501A (en) * | 1983-10-26 | 1988-08-02 | American Home Products Corporation | Substituted phenylacetamides |
| IE60311B1 (en) | 1987-09-24 | 1994-06-29 | American Home Prod | Sustained release etodolac |
| US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
| PT1738753E (pt) * | 1993-06-28 | 2008-06-19 | Wyeth Corp | Novos tratamentos utilizando derivados de fenetilamina |
| TW344661B (en) * | 1993-11-24 | 1998-11-11 | Lilly Co Eli | Pharmaceutical composition for treatment of incontinence |
| PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
-
1997
- 1997-03-04 PE PE00015497A patent/PE57198A1/es not_active IP Right Cessation
- 1997-03-05 PY PY199700970019A patent/PY970019A/es unknown
- 1997-03-05 AR ARP970100883 patent/AR006519A1/es unknown
- 1997-03-06 IL IL12038297A patent/IL120382A/xx unknown
- 1997-03-07 SK SK301-97A patent/SK281530B6/sk not_active IP Right Cessation
- 1997-03-07 TW TW86102797A patent/TW493993B/zh not_active IP Right Cessation
- 1997-03-10 SV SV1997000015A patent/SV1997000015A/es active IP Right Grant
- 1997-03-10 CO CO97012838A patent/CO4761054A1/es unknown
- 1997-03-11 EG EG18297A patent/EG24198A/xx active
- 1997-03-12 UA UA97031116A patent/UA44904C2/uk unknown
- 1997-03-12 CA CA 2199778 patent/CA2199778C/en not_active Expired - Lifetime
- 1997-03-13 TR TR97/00190A patent/TR199700190A2/xx unknown
- 1997-03-13 CZ CZ1997772A patent/CZ291637B6/cs not_active IP Right Cessation
- 1997-03-13 RU RU97103563A patent/RU2176912C2/ru not_active IP Right Cessation
- 1997-03-13 PL PL368424A patent/PL195564B1/pl unknown
- 1997-03-13 PL PL97318954A patent/PL188444B1/pl unknown
- 1997-03-14 NO NO19971206A patent/NO320355B1/no not_active IP Right Cessation
- 1997-03-14 PA PA8426401A patent/PA8426401A1/es unknown
- 1997-03-14 JP JP06078197A patent/JP4771565B2/ja not_active Expired - Fee Related
- 1997-03-14 CN CN97109594A patent/CN1090018C/zh not_active Expired - Lifetime
- 1997-03-14 HU HU9700589A patent/HU224617B1/hu not_active IP Right Cessation
- 1997-03-14 KR KR1019970008590A patent/KR101096512B1/ko not_active Expired - Lifetime
- 1997-03-14 BR BR9701304A patent/BR9701304A/pt not_active IP Right Cessation
- 1997-03-19 NZ NZ31444297A patent/NZ314442A/xx not_active IP Right Cessation
- 1997-03-19 ZA ZA972403A patent/ZA972403B/xx unknown
- 1997-03-20 AU AU16400/97A patent/AU727653B2/en not_active Expired
- 1997-03-21 IN IN507CA1997 patent/IN187337B/en unknown
- 1997-03-21 DE DE1997627000 patent/DE69727000T2/de not_active Expired - Lifetime
- 1997-03-21 AT AT97301937T patent/ATE257011T1/de active
- 1997-03-21 PT PT97301937T patent/PT797991E/pt unknown
- 1997-03-21 EP EP14198408.8A patent/EP2881110A1/en not_active Withdrawn
- 1997-03-21 ES ES97301937T patent/ES2210454T3/es not_active Expired - Lifetime
- 1997-03-21 EP EP19970301937 patent/EP0797991B1/en not_active Expired - Lifetime
- 1997-03-21 DK DK97301937T patent/DK0797991T3/da active
- 1997-07-10 UY UY24613A patent/UY24613A1/es not_active IP Right Cessation
-
2001
- 2001-12-14 CN CN01143869A patent/CN1403077A/zh active Pending
-
2004
- 2004-05-27 CY CY0400040A patent/CY2442B1/xx unknown
-
2005
- 2005-01-24 NO NO20050379A patent/NO20050379L/no not_active Application Discontinuation
-
2008
- 2008-03-13 JP JP2008064149A patent/JP2008156374A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1282698C (en) | Time controlled explosion systems and processes for preparing the same | |
| JP2007511510A (ja) | 持続放出性ベンラファキシン製剤 | |
| KR970064599A (ko) | 서방성 제형 | |
| CA2038245C (en) | Pharmaceutically useful micropellets | |
| JP4369752B2 (ja) | プロプラノロールの時限徐放性多粒子剤型 | |
| DK1126826T5 (en) | Multiparticle Modified Release Composition of Methylphenidate | |
| EP1465608B1 (en) | Extended release compositions comprising as active compound venlafaxine hydrochloride | |
| RU97103563A (ru) | Композиции длительного высвобождения венлафаксин гидрохлорида, композиция пленочного покрытия, способ обеспечения терапевтически активной концентрации венлафаксина и способ исключения нулевых и пиковых концентраций лекарственного средства | |
| IE59200B1 (en) | Therapeutic compositions for oral administration | |
| AU3492201A (en) | Timed pulsatile drug delivery systems | |
| US10213389B2 (en) | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | |
| WO2006063078A2 (en) | Topiramate pharmaceuticals composition | |
| AU2005279329A1 (en) | Pharmaceutical multiparticulate compositions comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin | |
| CA2068980A1 (en) | Diltiazem formulation | |
| JP2004532828A5 (2) | ||
| GB2098867A (en) | Sustained release pharmaceutical composition | |
| CA2627951A1 (en) | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | |
| WO1999042087A3 (en) | Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content | |
| CA2433915A1 (en) | Improved controlled release oral dosage form | |
| RU99125610A (ru) | Твердые фармацевтические препараты, содержащие физическую смесь сульфоалкилового эфира циклодекстрина и терапевтического агента | |
| CN112891322A (zh) | 右旋布洛芬制剂及其制备方法 | |
| AU2004229146A1 (en) | Venlafaxine compositions comprising pellets with double layer coating | |
| US20090297602A1 (en) | Modified Release Loxoprofen Compositions | |
| EP2531180A2 (en) | Oral complex composition comprising pseudoephedrine and levocetirizine | |
| JPS60228410A (ja) | 持続性製剤 |